Foreign Secretary Harsh V Shringla has said that India is working with several other countries in the World Trade Organization on a targeted and temporary waiver under TRIPS to ensure timely and secure access to vaccines for all. He said India is also looking forward to World Health Organization’s approval for India’s indigenous vaccine Covaxin manufactured by Bharat Biotech.
While addressing at the WHO’s South-East Asia Regional Health Partners Forum on COVID-19 today, Mr. Shringla has said, India is dealing with unprecedented economic and social disruptions due to challenges posed by the Covid-19. He said, these challenges require a response at multiple levels. He said, it requires not just a whole-of-government approach but a whole-of-society approach. He added that it also requires to source solutions and capacities on a global basis.
Highlighting the efforts of the Ministry of External Affairs in the fight against the Covid-19 pandemic, the Foreign Secretary has said that the Ministry has acted as the global arm of the Government of India’s Empowered Group to procure essential raw materials and medical supplies for COVID-19. He said it also played a key role in organizing the ‘Vande Bharat’ Mission which has facilitated the movement of seven million people.